Business Wire

Mary Kay Ash Foundation ® Gifts $500,000 Grant to Advance Cancer Research and Early Detection at Baylor Scott & White Health

13.11.2025 14:01:00 CET | Business Wire | Press Release

Share

The Mary Kay Ash Foundation®, a champion of women’s health innovation for nearly three decades, announced a $500,000 grant to Baylor Scott & White Dallas Foundation to accelerate a pioneering triple-negative breast cancer clinical trial and advance early detection initiatives that shift care from reactive to proactive at the newly established Texas Cancer Interception Institute.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113339900/en/

In recognition of its steadfast, decades-long commitment to women’s health, the Mary Kay Ash Foundation was honored with the prestigious Circle of Care Award at the 2025 Celebrating Women Luncheon, hosted by the Baylor Scott & White Dallas Foundation. The award celebrates those who have made a profound impact in shaping the future of breast cancer care through advocacy, philanthropy, and innovation. Since its inception, the luncheon has raised more than $42 million to fund research, advance detection, and support programs that empower women and families facing breast cancer. Photo Credit: Kristina Bowman

The two-fold grant includes:

  • $100,000 in continued support of a forward-thinking TRIM-EBC Clinical Trial led by world renowned Celebrating Women chair for Breast Cancer Research, Joyce O’Shaughnessy, MD. The trial explores the potential of weight-loss medications to reduce recurrence risk in overweight breast cancer patients.
  • The second part is a multi-year gift to the Texas Cancer Interception Institute, which aims to detect and intercept cancer at its earliest stages – when it is most treatable, will help shift women’s cancer narratives from “I have cancer,” to “I have cancer, but we caught it early.” Designed to be deployed on a broad scale, the program aims to revolutionize early detection and intervention strategies for better breast cancer survivorship and beyond.

This latest commitment underscores a shared mission between the two organizations: to invest in transformative cancer research that improves outcomes and brings us closer to curing cancers that disproportionately affect women. Over the past two decades, the Mary Kay Ash Foundation® has contributed $1.3 million to the Baylor Scott & White Dallas Foundation, reflecting an enduring alliance rooted in scientific discovery and compassion.

“The Mary Kay Ash Foundation remains committed to finding cures for cancers affecting women – we are championing for our mothers, daughters, sisters, and all the women in our lives,” said Michael Lunceford, President, Mary Kay Ash Foundation Board of Directors. “This grant represents a powerful next step in redefining cancer care – moving from a reactive nature to early detection and viable treatment options – with the goal of a long, healthy life after cancer. We are honored to stand alongside Baylor Scott & White in shaping the future of women’s health.”

In recognition of its steadfast, decades-long commitment to women’s health, the Mary Kay Ash Foundation was honored with the prestigious Circle of Care Award at the 2025 Celebrating Women Luncheon, hosted by the Baylor Scott & White Dallas Foundation. The award celebrates those who have made a profound impact in shaping the future of breast cancer care through advocacy, philanthropy, and innovation. Since its inception, the luncheon has raised more than $42 million to fund research, advance detection, and support programs that empower women and families facing breast cancer.

“Mary Kay Ash believed in the power of women to change the world – that conviction lives on through her namesake Foundation’s bold commitment to advancing women’s health by investing in early detection and better treatments,” said Christina Goodman, President, Baylor Scott & White Dallas Foundation. “When brilliant minds like Dr. Joyce O’Shaughnessy, MD and compassionate hearts come together, extraordinary things happen. This partnership is focused on bringing hope, healing, and new possibilities to patients and families across our communities.”

Did You Know?

Mary Kay is committed to ending cancers affecting women globally with its impact extending around the world through research funding and awareness campaigns driven by Mary Kay markets on multiple continents:

  • In Spain, Mary Kay partners with the FERO Foundation to support metastatic breast cancer research.
  • In Brazil, the Instituto Mary Kay funds cancer education and screening programs reaching thousands of women annually.
  • In Malaysia, Mary Kay collaborates with the National Cancer Society of Malaysia to promote early detection.
  • In Canada, the Mary Kay Ash Charitable Foundation supports Look Good Feel Better® workshops for women undergoing cancer treatment and provides product donations to help women feel beautiful after cancer.

Together, Mary Kay Inc., its global markets, and its four company-sponsored foundations and charitable funds have contributed nearly $44 million worldwide to help eliminate cancers affecting women. Learn more about Mary Kay’s ongoing global impact – from advancing women’s health and empowerment to protecting natural resources and fostering lasting change – in the 2025 Sustainability Report.

About Mary Kay Ash Foundation®

Guided by Mary Kay Ash’s dream to enrich the lives of women everywhere, the Mary Kay Ash Foundation® raises and distributes funds to end domestic violence and invest in breakthrough cancer research to find cures for women-related cancers. Since 1996, the Mary Kay Ash Foundation has contributed more than $98 million to organizations aligned with its two-fold mission. In addition, the Foundation supports awareness initiatives, community outreach programs, and advocates for legislation to ensure women are healthy and safe. Together, we can make the world better for women. To learn more about how to educate, advocate, volunteer, donate, and join life-saving work to support and empower women, visit marykayashfoundation.org, or find us on Facebook and Instagram.

About Baylor Scott & White Dallas Foundation

Baylor Scott & White Dallas Foundation raises money to advance the Mission of Baylor Scott & White Health: Founded as a Christian ministry of healing, Baylor Scott & White Health promotes the well-being of all individuals, families and communities. At Baylor Scott & White Dallas Foundation, philanthropy is the catalyst for change – advancing innovation, expanding access to compassionate care and empowering more people to live well. Together, we are shaping the future of healthcare in North Texas.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251113339900/en/

Contacts

Mary Kay Ash Foundation®
Newsroom.marykay.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2FNewsroom.maryka
y.com&esheet=54357189&newsitemid=20251113339900&lan=en-US&anchor=Newsroom.maryka
y.com&index=14&md5=240c9ba538b2a08d61110bbf6901135c
info@marykayashfoundation.org

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press Release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press Release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press Release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 06:30:00 CEST | Press Release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press Release

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales, reshaping channel strategies 49% of consumers are willing to pay more for locally made products, ref

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye